LMT
29
2
AVY
53
3
FTI
66
2
NWSA
78
5
KHC
20
2
CINF
40
5
HSIC
36
-9
BK
69
4
ADI
45
-2
FOXA
63
3
NTAP
54
2
STI
28
9
AZO
50
2
AVGO
32
7
IPG
50
2
F
42
2
STX
53
3
TROW
54
6
MCO
67
3
NRG
67
8
LMT
29
2
AVY
53
3
FTI
66
2
NWSA
78
5
KHC
20
2
CINF
40
5
HSIC
36
-9
BK
69
4
ADI
45
-2
FOXA
63
3
NTAP
54
2
STI
28
9
AZO
50
2
AVGO
32
7
IPG
50
2
F
42
2
STX
53
3
TROW
54
6
MCO
67
3
NRG
67
8
Financhill
Back

Crinetics Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
68

CRNX
Crinetics Pharmaceuticals

Last Price:
59.10
Seasonality Move:
10.45%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Crinetics Pharmaceuticals Price Quote

$59.10
+1.29 (+2.23%)
(Updated: November 6, 2024 at 5:55 PM ET)

Crinetics Pharmaceuticals Key Stats

Buy
68
Crinetics Pharmaceuticals (CRNX) is a Buy
Day range:
$55.28 - $57.88
52-week range:
$25.75 - $60.04
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.57%
Volume:
326.4K
Avg. volume:
744.6K
1-year change:
88.31%
Market cap:
$4.6B
Revenue:
$4M
EPS:
$-3.78

How Much Does Crinetics Pharmaceuticals Make?

Data Unavailable

Is Crinetics Pharmaceuticals Growing As A Company?

Crinetics Pharmaceuticals Stock Price Performance

What Is Crinetics Pharmaceuticals 52-Week High & Low?

Crinetics Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Crinetics Pharmaceuticals?

Is Crinetics Pharmaceuticals Cash Flow Positive?

  • What Is CRNX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$178.3M
  • What Is Crinetics Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $774.9M
  • What Is Crinetics Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$333.9M

Crinetics Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CRNX return on invested capital is -42.43%
  • What Is Crinetics Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -37.11%
  • What Is CRNX Return On Equity?
    ROE is a measure of profitability and is -42.43%

Crinetics Pharmaceuticals Earnings Date & Stock Price

Crinetics Pharmaceuticals Competitors

Crinetics Pharmaceuticals Dividend Yield

Crinetics Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.79%
Revenue: -59.62% -14.61%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 70.07
Upside from Last Price: 21.21%

Major Shareholders

  • How many CRNX shares are owned by institutional investors?
    128.4M CRNX shares are owned by institutional investors
  • How many CRNX shares are owned by insiders?
    950K CRNX shares are owned by insiders